Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been incorporated as guideline-directed medical therapy for heart failure with reduced ejection fraction. Recent trials clearly established the efficacy of SGLT2 inhibitors on cardiac remodeling while preventing renal function decline in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Ting-Wei, Huang, Chin-Chou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808402/
https://www.ncbi.nlm.nih.gov/pubmed/36606275
http://dx.doi.org/10.3389/fcvm.2022.1086672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808402/
https://www.ncbi.nlm.nih.gov/pubmed/36606275
http://dx.doi.org/10.3389/fcvm.2022.1086672

Ejemplares similares